JX10
JX10 is a senomorphic agent. JX10 suppresses the expression of p38 MAPK and NF-κB. JX10 exhibits competent antiaging effects in C. elegans, senescent cells, and aged mice[1].
Product Specifications
UNSPSC
12352005
Target
NF-κB; p38 MAPK
Related Pathways
MAPK/ERK Pathway; NF-κB
Field of Research
Metabolic Disease
Smiles
FC1=C(C=C(C2=C1)N(C(C3=CC=C(C=C3)OC)=CC2=O)C4CC4)N5CCN(CC5)CC
Molecular Formula
C25H28FN3O2
Molecular Weight
421.51
References & Citations
[1]Qiao S, et al. Discovery of Non-antibacterial Enrofloxacin Derivatives with Emerging Antiaging Effects through Drug Repurposing and Secondary Development. J Med Chem. 2025 May 9.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 3
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1194145-01 0.05 mg (E-Coli)
Recombinant Actinobacillus pleuropneumoniae serotype 3 Lysine--tRNA ligase (lysS)
Ask
View Details 
MBS1194145-02 0.05 mg (Baculovirus)
Recombinant Actinobacillus pleuropneumoniae serotype 3 Lysine--tRNA ligase (lysS)
Ask
View Details MBS1194145-03 0.2 mg (E-Coli)
Recombinant Actinobacillus pleuropneumoniae serotype 3 Lysine--tRNA ligase (lysS)
Ask
View Details MBS1194145-04 0.2 mg (Yeast)
Recombinant Actinobacillus pleuropneumoniae serotype 3 Lysine--tRNA ligase (lysS)
Ask
View Details MBS1194145-05 0.5 mg (E-Coli)
Recombinant Actinobacillus pleuropneumoniae serotype 3 Lysine--tRNA ligase (lysS)
Ask
View Details 
MBS1194145-06 0.05 mg (Mammalian-Cell)
Recombinant Actinobacillus pleuropneumoniae serotype 3 Lysine--tRNA ligase (lysS)
Ask
View Details